Analysis of very elderly (≥80years) non-hodgkin lymphoma: Impact of functional status and co-morbidities on outcome

Chadi Nabhan, Sonali M. Smith, Irene Helenowski, Erika Ramsdale, Benjamin Parsons, Reem Karmali, Josephine Feliciano, Britt Hanson, Scott Smith, June Mckoy, Annette Larsen, Andrew Hantel, Stephanie Gregory, Andrew M. Evens

Research output: Contribution to journalArticle

Abstract

Data on outcome, prognostic factors, and treatment for very elderly non-Hodgkin lymphomas (NHL) is sparse. We conducted a multicentre retrospective analysis of NHL patients ≥80years (at diagnosis) treated between 1999 and 2009. Detailed characteristics were obtained including geriatric syndromes, activities of daily living (ADLs), and co-morbidities using the Cumulative Illness Rating Scale-Geriatrics (CIRS-G). We identified 303 patients: 170 aggressive NHL (84% B cell/16% T cell) and 133 indolent NHL (82% B cell/18% T cell). Median age was 84years (80-95). A geriatric syndrome was present in 26% of patients, 18% had ≥1 grade 4 CIRS-G, and 14% had loss of ADLs. At 49-month median follow-up, 4-year progression-free (PFS) and overall survival (OS) for aggressive NHLs were 31% and 44% respectively (stage I/II: PFS 53% and OS 66%; stage III/IV: PFS 20% and OS 32%; P<0·0001 and 0·0002, respectively). Four-year PFS and OS for indolent NHL were 44% and 66% respectively, regardless of stage. Multivariate regression analysis identified two key factors that predicted inferior PFS and OS for both NHL groups: lack of CR and loss of ADLs. Prospective studies for very elderly NHL that incorporate geriatric tools, especially ADLs, are warranted.

Original languageEnglish (US)
Pages (from-to)196-204
Number of pages9
JournalBritish Journal of Haematology
Volume156
Issue number2
DOIs
StatePublished - Jan 2012
Externally publishedYes

Fingerprint

Non-Hodgkin's Lymphoma
Geriatrics
Morbidity
Activities of Daily Living
Survival
B-Lymphocytes
T-Lymphocytes
Multivariate Analysis
Regression Analysis
Prospective Studies

Keywords

  • Co-morbidities
  • Elderly
  • Functional status
  • Geriatric syndromes
  • Non-Hodgkin lymphoma

ASJC Scopus subject areas

  • Hematology

Cite this

Analysis of very elderly (≥80years) non-hodgkin lymphoma : Impact of functional status and co-morbidities on outcome. / Nabhan, Chadi; Smith, Sonali M.; Helenowski, Irene; Ramsdale, Erika; Parsons, Benjamin; Karmali, Reem; Feliciano, Josephine; Hanson, Britt; Smith, Scott; Mckoy, June; Larsen, Annette; Hantel, Andrew; Gregory, Stephanie; Evens, Andrew M.

In: British Journal of Haematology, Vol. 156, No. 2, 01.2012, p. 196-204.

Research output: Contribution to journalArticle

Nabhan, C, Smith, SM, Helenowski, I, Ramsdale, E, Parsons, B, Karmali, R, Feliciano, J, Hanson, B, Smith, S, Mckoy, J, Larsen, A, Hantel, A, Gregory, S & Evens, AM 2012, 'Analysis of very elderly (≥80years) non-hodgkin lymphoma: Impact of functional status and co-morbidities on outcome', British Journal of Haematology, vol. 156, no. 2, pp. 196-204. https://doi.org/10.1111/j.1365-2141.2011.08934.x
Nabhan, Chadi ; Smith, Sonali M. ; Helenowski, Irene ; Ramsdale, Erika ; Parsons, Benjamin ; Karmali, Reem ; Feliciano, Josephine ; Hanson, Britt ; Smith, Scott ; Mckoy, June ; Larsen, Annette ; Hantel, Andrew ; Gregory, Stephanie ; Evens, Andrew M. / Analysis of very elderly (≥80years) non-hodgkin lymphoma : Impact of functional status and co-morbidities on outcome. In: British Journal of Haematology. 2012 ; Vol. 156, No. 2. pp. 196-204.
@article{ceced71f9e084baa8aec8c75befa9af4,
title = "Analysis of very elderly (≥80years) non-hodgkin lymphoma: Impact of functional status and co-morbidities on outcome",
abstract = "Data on outcome, prognostic factors, and treatment for very elderly non-Hodgkin lymphomas (NHL) is sparse. We conducted a multicentre retrospective analysis of NHL patients ≥80years (at diagnosis) treated between 1999 and 2009. Detailed characteristics were obtained including geriatric syndromes, activities of daily living (ADLs), and co-morbidities using the Cumulative Illness Rating Scale-Geriatrics (CIRS-G). We identified 303 patients: 170 aggressive NHL (84{\%} B cell/16{\%} T cell) and 133 indolent NHL (82{\%} B cell/18{\%} T cell). Median age was 84years (80-95). A geriatric syndrome was present in 26{\%} of patients, 18{\%} had ≥1 grade 4 CIRS-G, and 14{\%} had loss of ADLs. At 49-month median follow-up, 4-year progression-free (PFS) and overall survival (OS) for aggressive NHLs were 31{\%} and 44{\%} respectively (stage I/II: PFS 53{\%} and OS 66{\%}; stage III/IV: PFS 20{\%} and OS 32{\%}; P<0·0001 and 0·0002, respectively). Four-year PFS and OS for indolent NHL were 44{\%} and 66{\%} respectively, regardless of stage. Multivariate regression analysis identified two key factors that predicted inferior PFS and OS for both NHL groups: lack of CR and loss of ADLs. Prospective studies for very elderly NHL that incorporate geriatric tools, especially ADLs, are warranted.",
keywords = "Co-morbidities, Elderly, Functional status, Geriatric syndromes, Non-Hodgkin lymphoma",
author = "Chadi Nabhan and Smith, {Sonali M.} and Irene Helenowski and Erika Ramsdale and Benjamin Parsons and Reem Karmali and Josephine Feliciano and Britt Hanson and Scott Smith and June Mckoy and Annette Larsen and Andrew Hantel and Stephanie Gregory and Evens, {Andrew M.}",
year = "2012",
month = "1",
doi = "10.1111/j.1365-2141.2011.08934.x",
language = "English (US)",
volume = "156",
pages = "196--204",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Analysis of very elderly (≥80years) non-hodgkin lymphoma

T2 - Impact of functional status and co-morbidities on outcome

AU - Nabhan, Chadi

AU - Smith, Sonali M.

AU - Helenowski, Irene

AU - Ramsdale, Erika

AU - Parsons, Benjamin

AU - Karmali, Reem

AU - Feliciano, Josephine

AU - Hanson, Britt

AU - Smith, Scott

AU - Mckoy, June

AU - Larsen, Annette

AU - Hantel, Andrew

AU - Gregory, Stephanie

AU - Evens, Andrew M.

PY - 2012/1

Y1 - 2012/1

N2 - Data on outcome, prognostic factors, and treatment for very elderly non-Hodgkin lymphomas (NHL) is sparse. We conducted a multicentre retrospective analysis of NHL patients ≥80years (at diagnosis) treated between 1999 and 2009. Detailed characteristics were obtained including geriatric syndromes, activities of daily living (ADLs), and co-morbidities using the Cumulative Illness Rating Scale-Geriatrics (CIRS-G). We identified 303 patients: 170 aggressive NHL (84% B cell/16% T cell) and 133 indolent NHL (82% B cell/18% T cell). Median age was 84years (80-95). A geriatric syndrome was present in 26% of patients, 18% had ≥1 grade 4 CIRS-G, and 14% had loss of ADLs. At 49-month median follow-up, 4-year progression-free (PFS) and overall survival (OS) for aggressive NHLs were 31% and 44% respectively (stage I/II: PFS 53% and OS 66%; stage III/IV: PFS 20% and OS 32%; P<0·0001 and 0·0002, respectively). Four-year PFS and OS for indolent NHL were 44% and 66% respectively, regardless of stage. Multivariate regression analysis identified two key factors that predicted inferior PFS and OS for both NHL groups: lack of CR and loss of ADLs. Prospective studies for very elderly NHL that incorporate geriatric tools, especially ADLs, are warranted.

AB - Data on outcome, prognostic factors, and treatment for very elderly non-Hodgkin lymphomas (NHL) is sparse. We conducted a multicentre retrospective analysis of NHL patients ≥80years (at diagnosis) treated between 1999 and 2009. Detailed characteristics were obtained including geriatric syndromes, activities of daily living (ADLs), and co-morbidities using the Cumulative Illness Rating Scale-Geriatrics (CIRS-G). We identified 303 patients: 170 aggressive NHL (84% B cell/16% T cell) and 133 indolent NHL (82% B cell/18% T cell). Median age was 84years (80-95). A geriatric syndrome was present in 26% of patients, 18% had ≥1 grade 4 CIRS-G, and 14% had loss of ADLs. At 49-month median follow-up, 4-year progression-free (PFS) and overall survival (OS) for aggressive NHLs were 31% and 44% respectively (stage I/II: PFS 53% and OS 66%; stage III/IV: PFS 20% and OS 32%; P<0·0001 and 0·0002, respectively). Four-year PFS and OS for indolent NHL were 44% and 66% respectively, regardless of stage. Multivariate regression analysis identified two key factors that predicted inferior PFS and OS for both NHL groups: lack of CR and loss of ADLs. Prospective studies for very elderly NHL that incorporate geriatric tools, especially ADLs, are warranted.

KW - Co-morbidities

KW - Elderly

KW - Functional status

KW - Geriatric syndromes

KW - Non-Hodgkin lymphoma

UR - http://www.scopus.com/inward/record.url?scp=84155180784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84155180784&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2011.08934.x

DO - 10.1111/j.1365-2141.2011.08934.x

M3 - Article

C2 - 22084970

AN - SCOPUS:84155180784

VL - 156

SP - 196

EP - 204

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -